Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

More articles from 1-Minute Consult

  • You have access
    Should all patients with acute pericarditis be treated with colchicine?
    Heath Saltzman, MD and Howard H. Weitz, MD
    Cleveland Clinic Journal of Medicine May 2007, 74 (5) 385-386;

    Colchicine should be considered a first-line treatment for acute pericarditis and for preventing recurrent episodes.

  • You have access
    At what age should we discontinue colon cancer screening in the elderly?
    Rachelle Losey, MD and Barbara J. Messinger-Rapport, MD, PhD
    Cleveland Clinic Journal of Medicine April 2007, 74 (4) 269-272;

    In general, you should stop when you do not expect the patient to live 7 to 10 more years. However, the full answer is more complicated.

  • You have access
    Which agents should we use to treat and prevent influenza in 2006–2007?
    Sherif B. Mossad, MD
    Cleveland Clinic Journal of Medicine November 2006, 73 (11) 1016-1018;

    Oseltamivir (Tamiflu) and zanamivir (Relenza) are the treatments of choice this year, but vaccination remains the primary preventive measure.

  • You have access
    When can patients with acute deep vein thrombosis be allowed to get up and walk?
    Leonard S. Feldman, MD and Daniel J. Brotman, MD
    Cleveland Clinic Journal of Medicine October 2006, 73 (10) 893-896;

    They should ambulate as tolerated. Bed rest is not evidence-based and may be harmful.

  • You have access
    When should prophylactic anticoagulation begin after a hip fracture?
    Paul J. Grant, md and Amir K. Jaffer, MD
    Cleveland Clinic Journal of Medicine September 2006, 73 (9) 785-792;

    The short answer is immediately, but several issues need consideration before starting.

  • You have access
    How often should patients with hepatitis C be screened for esophageal varices?
    Christopher Entwisle, MD and Zobair M. Younossi, MD, MPH
    Cleveland Clinic Journal of Medicine August 2006, 73 (8) 758-759;

    If the patient has cirrhosis, screen promptly with upper endoscopy. If no varices are found, repeat endoscopy every 2 years.

  • You have access
    Should beta-blockers be discontinued when a patient is admitted to the hospital with acutely decompensated heart failure?
    Wassim H. Fares, MD and Ashish Aneja, MD
    Cleveland Clinic Journal of Medicine June 2006, 73 (6) 557-559;

    Hard data on this topic are scant, but the answer depends on the patient’s perfusion status and vital signs.

  • You have access
    How should we advise patients about the contraceptive patch, given the FDA warning?
    Holly L. Thacker, MD, Tommaso Falcone, MD, Ashish Atreja, MD, MPH, Anil Jain, MD and C. Martin Harris, MD, MBA
    Cleveland Clinic Journal of Medicine January 2006, 73 (1) 45-47;

    In theory, patients could face a higher risk of thromboembolism than with oral contraceptives. But most of all we want to urge them not to simply stop using contraception.

  • You have access
    What is osteopenia, and what should be done about it?
    Nelson B. Watts, MD
    Cleveland Clinic Journal of Medicine January 2006, 73 (1) 29-32;

    Because the term “osteopenia” is not useful as a diagnosis and can actually be harmful, I am on a personal crusade to eliminate it from the bone density lexicon.

  • You have access
    How long can my patient use intranasal steroid sprays?
    Lily C. Pien, MD
    Cleveland Clinic Journal of Medicine December 2005, 72 (12) 1079-1082;

    There is little evidence to indicate they cause significant systemic side effects. However, patients who use them regularly should undergo examinations of the nasal cavity at least once a year to check for damage to the septum.

Pages

  • Previous
  • Next
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 28

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire